Use of human papillomavirus testing in the management of atypical glandular cells

Journal of Lower Genital Tract Disease

Volumn 13, Issue 2, 2009, Pages 94-101

  Schnatz, Peter F ^a,b   Sharpless, Kathryn E ^c   O'Sullivan, David M ^a  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Atypical glandular cells (AGCs); Cytology and dysplasia; Diagnostic techniques and procedures; Human papillomavirus; Pap test and cervical cancer screening

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; ATYPICAL GLANDULAR CELL; COLPOSCOPY; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; ENDOMETRIAL DISEASE; EVALUATION; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; SENSITIVITY ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX TUMOR; VIRUS EXAMINATION; WART VIRUS; ADOLESCENT; AGED; COHORT ANALYSIS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; UTERINE CERVIX DYSPLASIA; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

VIRUS DNA;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 67650714438     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e318183a438     Document Type: Article

References (29)

1. Johnson T, Schnatz PF, Johnson AM, Sorosky JI. Update on cervical cancer screening. Hosp Phys 2007;43:15-24.
2. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24- year population-based study. Gynecol Oncol 2000;78: 97-105.
3. van Aspert-van Erp AJ, Smedts FM, Vooijs GP. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the Papanicolaou smear. Cancer 2004;102:210-217
4. Krane JF, Granter SR, Trask CE, Hogan CL, Lee KR. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix. Cancer 2001;93:8-15.
5. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda system, terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
6. Wright TC, Massad S, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 Consensus guidelines for the management of women with abnormal cervical screening tests. J Lower Genit Tract Dis 2007;11:201-222
7. Schnatz PF, Guile M, O'Sullivan DM, Sorosky JI. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol 2006;107:701-708 (Pubitemid 43755628)
8. Levine L, Lucci JA, Dinh TV. Atypical glandular cells: new Bethesda terminology and management guidelines. Obstet Gynecol Surv 2003;58:399-406. (Pubitemid 36666553)
9. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Dysplasia associated with atypical glandular cells on cervical cytology. Obstet Gynecol 2005;105:494-500. (Pubitemid 40271212)
10. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19 (Pubitemid 29406813)
11. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299 (Pubitemid 32219816)
12. The ASCUS-LSIL Triage Study Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-1392
13. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12: 186-192
14. U.S. Department of Labor; Bureau of Labor Statistics. Available at: http://www.bls.gov/oes/current/msa-def.htm#3280. Accessed June 15, 2008.
15. Sharpless KE, O'Sullivan DM, Schnatz PF. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology. J Lower Genit Tract Dis 2003;13:72-78.
16. Cox JT, Schiffman M, Solomon D. Prospective followup suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. ASCUS-LSILTriage Study (ALTS) Group. Am J Obstet Gynecol 2003;188:1406-1412 (Pubitemid 36741266)
17. Jeronimo J, Schiffman M. Colposcopy at the crossroads. Am J Obstet Gynecol 2006;195:349-353
18. Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, et al. Number of cervical biopsies and sensitivities of colposcopy. Obstet Gynecol 2006;108:264-272
19. Kietpeerakool C, Srisomboon J, Prompittayarat W, Kanjanavaha P, Peuwsai R, Dheerakul C. Can adenocarcinoma of the uterine cervix be predicted before cervical conization? Asian Pac J Cancer Prev 2006;7:522-524
20. Shin CH, Schorge JO, Lee KR, Sheets EE. Cytologic and biopsy findings leading to conization in adenocarcinoma in situ of the cervix. Obstet Gynecol 2002;100:271-276 (Pubitemid 34874789)
21. Saqi A, Gupta PK, Erroll M, Babiac A, Blackmun D, Mansukhani M, et al. High-risk human papillomavirus testing: a marker for atypical glandular cells. Diagn Cytopathol 2006;34:235-239
22. Oliveira ER, Derchain SF, Sarian LO, Rabelo-Santos SH, Gontijo RC, Yoshida A, et al. Prediction of high-grade cervical disease with human papillomavirus detection in women with glandular and squamous cytologic abnormalities. Int J Gynecol Cancer 2006;16:1055-1062 (Pubitemid 43886726)
23. Diaz-Montes TP, Farinola MA, Zahurak ML, Bristow RE, Rosenthal DL. Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results. Gynecol Oncol 2007;104:366-371
24. Irvin W, Evans SR, Andersen W, Jazaeri A, Taylor P, Stoler M, et al. The utility of HPV DNA triage in the management of cytological AGC. Am J Obstet Gynecol 2005; 193:559-565 (Pubitemid 41159556)
25. Chen SF,Yang SF, ChuTY, LaiHC, LinYW, BaiCY, et al. Which test is a better strategy to determine the outcome of atypical glandular cell-categorized Pap smears? Immunocytochemical p16INK4A expression or human papillomavirus testVa restrospective cohort study. Gynecol Oncol 2005; 99:578-584
26. Derchain SF, Rabelo-Santos SH, Sarian LO, Zeferino LC, de Oliveira Zambeli ER, do Amaral Westin MC, et al. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol 2004;95:618-623
27. Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kinney WK, Hurley LB, et al. Atypical glandular cells of undetermined significant (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-825
28. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology. Obstet Gynecol 2005;105:501-506 (Pubitemid 40271213)
29. Castle PE, Lorincz AT, Mielzynska-Lohnas I, Scott DR, Glass AG, Sherman ME, et al. Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible. J Clin Microbiol 2002;40:1088-1090 (Pubitemid 34208677)